Axsome Therapeutics, Inc. (AXSM)
149.17
+3.95
(+2.72%)
USD |
NASDAQ |
Dec 10, 16:00
149.17
0.00 (0.00%)
After-Hours: 20:00
Axsome Therapeutics Market Cap: 7.520B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.535B |
| Fortress Biotech, Inc. | 91.56M |
| TG Therapeutics, Inc. | 4.854B |
| Karyopharm Therapeutics, Inc. | 109.81M |
| Viking Therapeutics, Inc. | 4.242B |
Market Cap Related Metrics
| PS Ratio | 13.08 |
| Price to Book Value | 102.00 |
| Price | 149.17 |
| Earnings Yield | -3.13% |